2,654
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Recombinant adeno-associated virus serotype 9 AAV-RABVG expressing a Rabies Virus G protein confers long-lasting immune responses in mice and non-human primates

, , , , , , , , , & show all
Pages 1439-1451 | Received 27 Jan 2022, Accepted 11 May 2022, Published online: 26 May 2022

References

  • Huang J, Zhang Y, Huang Y, et al. The ectodomain of rabies virus glycoprotein determines dendritic cell activation. Antiviral Res. 2017 May;141:1-6. doi:10.1016/j.antiviral.2017.01.022 PubMed PMID: 28161580.
  • El-Sayed A. Advances in rabies prophylaxis and treatment with emphasis on immunoresponse mechanisms. Int J Vet Sci Med. 2018 Jun;6(1):8–15. doi:10.1016/j.ijvsm.2018.05.001 PubMed PMID: 30255072; PubMed Central PMCID: PMCPMC6149183.
  • Potratz M, Zaeck LM, Weigel C, et al. Neuroglia infection by rabies virus after anterograde virus spread in peripheral neurons. Acta Neuropathol Commun. 2020 Nov 23;8(1):199, doi:10.1186/s40478-020-01074-6 PubMed PMID: 33228789; PubMed Central PMCID: PMCPMC7684951.
  • Zhenfang F. Rabies and rabies- research past, present and future. Vaccine. 1997;15:20–24. doi:10.1016/S0264-410X(96)00122-3
  • Wirblich C, Schnell MJ. Rabies virus (RV) glycoprotein expression levels are not critical for pathogenicity of RV. J Virol. 2011 Jan;85(2):697–704. doi:10.1128/JVI.01309-10 PubMed PMID: 21068252; PubMed Central PMCID: PMCPMC3020019.
  • World Health Organization. WHO expert consultation on rabies: third report. Geneva: WHO technical report series; 2018; 1012.
  • Fooks AR, Cliquet F, Finke S, et al. Rabies. Nat Rev Dis Primers. 2017 Nov 30;3:17091, doi:10.1038/nrdp.2017.91 PubMed PMID: 29188797.
  • Davis BM, Rall GF, Schnell MJ. Everything you always wanted to know about rabies virus (but were afraid to ask). Annu Rev Virol. 2015;2(1):451–471. doi:10.1146/annurev-virology-100114-055157.
  • Du Pont V, Plemper RK, Schnell MJ. Status of antiviral therapeutics against rabies virus and related emerging lyssaviruses. Curr Opin Virol. 2019 Apr;35:1–13. doi:10.1016/j.coviro.2018.12.009 PubMed PMID: 30753961; PubMed Central PMCID: PMCPMC6556400.
  • Davlin SL, Vonville HM. Canine rabies vaccination and domestic dog population characteristics in the developing world: a systematic review. Vaccine. 2012 May 21;30(24):3492–3502. doi:10.1016/j.vaccine.2012.03.069 PubMed PMID: 22480924.
  • Franka R, Smith TG, Dyer JL, et al. Current and future tools for global canine rabies elimination. Antiviral Res. 2013 Oct;100(1):220–225. doi:10.1016/j.antiviral.2013.07.004 PubMed PMID: 23871797.
  • Hicks DJ, Fooks AR, Johnson N. Developments in rabies vaccines. Clin Exp Immunol. 2012 Sep;169(3):199–204. doi:10.1111/j.1365-2249.2012.04592.x PubMed PMID: 22861358; PubMed Central PMCID: PMCPMC3444995.
  • Katz ISS, Guedes F, Fernandes ER, et al. Immunological aspects of rabies: a literature review. Arch Virol. 2017 Nov;162(11):3251–3268. doi:10.1007/s00705-017-3484-0 PubMed PMID: 28726129.
  • Both L, Banyard AC, van Dolleweerd C, et al. Passive immunity in the prevention of rabies. Lancet Infect Dis. 2012;12(5):397–407. doi:10.1016/S1473-3099(11)70340-1.
  • Tarantola A. Four thousand years of concepts relating to rabies in animals and humans. Its Prevention and Its Cure. Tropical Medicine and Infectious Disease. 2017;2(4):5, doi:10.3390/tropicalmed2020005.
  • Banyard AC, Mansfield KL, Wu G, et al. Re-evaluating the effect of Favipiravir treatment on rabies virus infection. Vaccine. 2019 Aug 2;37(33):4686–4693. doi:10.1016/j.vaccine.2017.10.109 PubMed PMID: 29132993.
  • McGettigan JP. Experimental rabies vaccines for humans. Expert Rev Vaccines. 2010 Oct;9(10):1177–1186. doi:10.1586/erv.10.105 PubMed PMID: 20923268; PubMed Central PMCID: PMCPMC3072237.
  • Verdera HC, Kuranda K, Mingozzi F. AAV vector immunogenicity in humans: a long journey to successful gene transfer. Mol Ther. 2020 Mar 4;28(3):723–746. doi:10.1016/j.ymthe.2019.12.010 PubMed PMID: 31972133; PubMed Central PMCID: PMCPMC7054726.
  • Nidetz NF, McGee MC, Tse LV, et al. Adeno-associated viral vector-mediated immune responses: understanding barriers to gene delivery. Pharmacol Ther. 2020 Mar;207:107453, doi:10.1016/j.pharmthera.2019.107453 PubMed PMID: 31836454; PubMed Central PMCID: PMCPMC6980784.
  • Glybera-product-information. Summary of product characteristics. European Medicines Agency. 2012;1–35.
  • Bi L. (2017). Summary-Basis-for-Regulatory-Action – LUXTURNA. . Food and drug adminstration.
  • Weleber RG, Pennesi ME, Wilson DJ, et al. Results at 2 years after gene therapy for RPE65-deficient leber congenital amaurosis and severe early-childhood-onset retinal dystrophy. Ophthalmology. 2016 Jul;123(7):1606–1620. doi:10.1016/j.ophtha.2016.03.003 PubMed PMID: 27102010.
  • Xin K-Q, Urabe M, Yang J, et al. A novel recombinant adeno-associated virus vaccine induces a long-term humoral immune response to human immunodeficiency virus. Hum Gene Ther. 2001;12(9):1047–1061. doi:10.1089/104303401750214276
  • Kan F, Ye L, Yan T, et al. Proteomic and transcriptomic studies of HBV-associated liver fibrosis of an AAV-HBV-infected mouse model. BMC Genomics. 2017 Aug 22;18(1):641, doi:10.1186/s12864-017-3984-z PubMed PMID: 28830339; PubMed Central PMCID: PMCPMC5568174.
  • Yang X, Marcucci K, Anguela X, et al. Preclinical evaluation of an anti-HCV miRNA cluster for treatment of HCV infection. Mol Ther. 2013 Mar;21(3):588–601. doi:10.1038/mt.2012.247 PubMed PMID: 23295950; PubMed Central PMCID: PMCPMC3589168.
  • Ploquin A, Szecsi J, Mathieu C, et al. Protection against henipavirus infection by use of recombinant adeno-associated virus-vector vaccines. J Infect Dis. 2013 Feb 1;207(3):469–478. doi:10.1093/infdis/jis699 PubMed PMID: 23175762; PubMed Central PMCID: PMCPMC7107322.
  • Limberis MP, Adam VS, Wong G, et al. Intranasal antibody gene transfer in mice and ferrets elicits broad protection against pandemic influenza. Sci Transl Med. 2013 May 29;5(187):187ra72, doi:10.1126/scitranslmed.3006299. PubMed PMID: 23720583; PubMed Central PMCID: PMCPMC4596530.
  • Magnani DM, Ricciardi MJ, Bailey VK, et al. Dengue virus evades AAV-mediated neutralizing antibody prophylaxis in rhesus monkeys. Mol Ther. 2017 Oct 4;25(10):2323–2331. doi:10.1016/j.ymthe.2017.06.020 PubMed PMID: 28750738; PubMed Central PMCID: PMCPMC5628771.
  • Samaranch L, Salegio EA, San Sebastian W, et al. Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates. Hum Gene Ther. 2012 Apr;23(4):382–389. doi:10.1089/hum.2011.200 PubMed PMID: 22201473; PubMed Central PMCID: PMCPMC3327605.
  • Samaranch L, Perez-Canamas A, Soto-Huelin B, et al. Adeno-associated viral vector serotype 9-based gene therapy for niemann-pick disease type A. Sci Transl Med. 2019 Aug 21;11(506), doi:10.1126/scitranslmed.aat3738. PubMed PMID: 31434754; PubMed Central PMCID: PMCPMC7285630.
  • Astray RM, Jorge SA, Pereira CA. Rabies vaccine development by expression of recombinant viral glycoprotein. Arch Virol. 2017 Feb;162(2):323–332. doi:10.1007/s00705-016-3128-9 PubMed PMID: 27796547.
  • Wang ZW, Sarmento L, Wang Y, et al. Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system. J Virol. 2005 Oct;79(19):12554–12565. doi:10.1128/JVI.79.19.12554-12565.2005 PubMed PMID: 16160183; PubMed Central PMCID: PMCPMC1211539.
  • Cliquet F, Aubert M, Sagne L. Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody. J Immunol Methods. 1998 Mar 1;212(1):79–87. PubMed PMID: 9671155; eng. doi:10.1016/S0022-1759(97)00212-3
  • Tian D, Luo Z, Zhou M, et al. Critical role of K1685 and K1829 in the large protein of rabies virus in viral pathogenicity and immune evasion. J Virol. 2015;90(1):232–244. doi:10.1128/JVI.02050-15 PubMed PMID: 26468538; eng.
  • Wang Z, Li M, Zhou M, et al. A novel rabies vaccine expressing CXCL13 enhances humoral immunity by recruiting both T Follicular Helper and Germinal Center B Cells. J Virol. 2017 Feb 1;91(3), doi:10.1128/JVI.01956-16. PubMed PMID: 27852854; PubMed Central PMCID: PMCPMC5244327.
  • Nieto K, Salvetti A. AAV vectors vaccines against Infectious diseases. Front Immunol. 2014;5:5, doi:10.3389/fimmu.2014.00005 PubMed PMID: 24478774; PubMed Central PMCID: PMCPMC3896988.
  • Hanlon KS, Meltzer JC, Buzhdygan T, et al. Selection of an efficient AAV vector for robust CNS transgene expression. Mol Ther Methods Clin Dev. 2019 Dec 13;15:320–332. doi:10.1016/j.omtm.2019.10.007 PubMed PMID: 31788496; PubMed Central PMCID: PMCPMC6881693.
  • Fisher KJ, Jooss K, Alsto J, et al. Recombinant adena-associated virus for muscle directed gene therapy. Nature Publishing Group. 1997;3(3):306–312.
  • Jooss K, Yang Y, Fisher KJ, et al. Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers. J Virol. 1998 May;72(5):4212–4223. PubMed PMID: 9557710; PubMed Central PMCID: PMCPmc109650. eng. doi:10.1128/JVI.72.5.4212-4223.1998
  • Sarukhan A, Soudais C, Danos O, et al. Factors influencing cross-presentation of non-self antigens expressed from recombinant adeno-associated virus vectors. J Gene Med. 2001 May-Jun;3(3):260–270. doi:10.1002/jgm.175. PubMed PMID: 11437331; eng.
  • Ponnazhagan S. Adenoassociated virus vectors for genetic immunization. Immunol Res. 2002;26(1-3):247–253. doi:10.1385/IR:26:1-3:247 PubMed PMID: 12403362; eng.
  • Li X, Cao H, Wang Q, et al. Novel AAV-based genetic vaccines encoding truncated dengue virus envelope proteins elicit humoral immune responses in mice. Microbes Infect. 2012 Sep;14(11):1000–1007. doi:10.1016/j.micinf.2012.05.002 PubMed PMID: 22626929.
  • Kuck D, Lau T, Leuchs B, et al. Intranasal vaccination with recombinant adeno-associated virus type 5 against human papillomavirus type 16 L1. J Virol. 2006 Mar;80(6):2621–2630. doi:10.1128/JVI.80.6.2621-2630.2006 PubMed PMID: 16501072; PubMed Central PMCID: PMCPMC1395428.
  • Yan L, Zhao Z, Xue X, et al. A bivalent human adenovirus type 5 vaccine expressing the rabies virus glycoprotein and canine distemper virus hemagglutinin protein confers protective immunity in mice and foxes. Front Microbiol. 2020;11:1070–1012. doi:10.3389/fmicb.2020.01070 PubMed PMID: 32612580; PubMed Central PMCID: PMCPMC7309451.
  • Balan S, Saxena M, Bhardwaj N. Dendritic cell subsets and locations. Int Rev Cell Mol Biol. 2019;348:1–68. doi:10.1016/bs.ircmb.2019.07.004
  • Mosmann TR, Cherwinski H, Bond MW, et al. Two types of murine helper T cell clone. I. Definition According to Profiles of Lymphokine Activities and Secreted Proteins. J Immunol. 1986;136(7):2348–2357.
  • Luckheeram RV, Zhou R, Verma AD, et al. CD4(+)T cells: differentiation and functions. Clin Dev Immunol. 2012;2012:925135, doi:10.1155/2012/925135 PubMed PMID: 22474485; PubMed Central PMCID: PMC3312336.
  • Durai V, Murphy KM. Functions of murine dendritic cells. Immunity. 2016 Oct 18;45(4):719–736. doi:10.1016/j.immuni.2016.10.010 PubMed PMID: 27760337; PubMed Central PMCID: PMCPMC5145312.
  • Swain SL, McKinstry KK, Strutt TM. Expanding roles for CD4(+) T cells in immunity to viruses. Nat Rev Immunol. 2012 Jan 20;12(2):136–148. doi:10.1038/nri3152 PubMed PMID: 22266691; PubMed Central PMCID: PMCPMC3764486.
  • Li C, Narkbunnam N, Samulski RJ, et al. Neutralizing antibodies against adeno-associated virus examined prospectively in pediatric patients with hemophilia. Gene Ther. 2012 Mar;19(3):288–294. doi:10.1038/gt.2011.90 PubMed PMID: 21697954.